id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-D-0584-0001,FDA,FDA-2010-D-0584,Guidance for Industry on Abbreviated New Drug Applications; Availability: Impurities in Drug Products,Notice,Notice of Availability,2010-11-29T05:00:00Z,2010,11,2010-11-29T05:00:00Z,,2020-05-05T20:23:44Z,2010-29896,0,0,0900006480ba7cc3
FDA-2010-D-0584-0002,FDA,FDA-2010-D-0584,Guidance for Industry; ANDAs; Impurities in Drug Products,Other,Guidance,2010-11-26T05:00:00Z,2010,11,2010-11-26T05:00:00Z,,2024-11-12T23:19:31Z,,1,0,090000648456e7b4